此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

南亚和东南亚农村地区发热性疾病的发病率、原因和结果 (SEACTN-WP-A)

2026年9月30日 更新者:University of Oxford

作为南亚和东南亚社区试验网络 (SEACTN) 的一部分,确定南亚和东南亚农村发热性疾病 (RFI) 的发病率、原因和结果。工作包 A (WP-A)。

The study will collect information to understand the causes and outcomes of febrile illness in rural areas in countries across South and Southeast Asia (including Cambodia, Laos, Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that can improve the management of febrile patients in the future.

This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z

研究概览

地位

完全的

条件

详细说明

This study aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people living in rural areas in South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI project will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. Determining the incidence, causes and outcomes of febrile illness in these settings will be done through two work packages. The first of these, Work Package A (WP-A), the subject of this study, will be carried out at the community level, primarily by engaging village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities to recruit patients presenting with a febrile illness. These patients will be assessed for presenting symptoms and followed up for clinical outcomes. Collection of specimen for diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by VHWs and HCs in these networks, therefore by using the same process, but also applying blood to filter paper and allowing it to dry (DBS), investigators will test for certain other pathogens, which will increase the aetiological yield.

研究类型

观察性的

注册 (实际的)

82760

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Dhaka、孟加拉国、1212
        • Building Resources Across Communities (BRAC)
      • Battambang、柬埔寨
        • Action for Health Development (AHEAD)
      • Chiang Rai、泰国、57000
        • Chiangrai Clinical Research Unit (CCRU)
    • Bangkok
      • Ratchathewi、Bangkok、泰国、10400
        • Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)
    • Changwat Tak
      • Mae Sot、Changwat Tak、泰国、63110
        • Shoklo Malaria Research Unit (SMRU)
      • Yangon、缅甸、11201
        • Medical Action Myanmar (MAM)
    • Vientiane Prefecture
      • Vientiane、Vientiane Prefecture、老挝、01000
        • Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients with an acute febrile illness of all ages presenting to village health workers (VHWs) or peripheral health facilities.

描述

Inclusion Criteria:

  • Documented fever (≥ 37.5°C axillary), hypothermia (< 35.5°C) and/or history of fever in the last 24 hours.
  • Willingness and ability to comply with study protocol for the study duration.
  • Written informed consent given to participate in the trial.

Exclusion Criteria:

  • Currently enrolled in the study
  • Accident or trauma is the cause for presentation
  • Presentation ≤ 3 days after routine immunisations

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:CASE_ONLY
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
Patients with febrile illness

Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Local incidence of febrile illness
大体时间:From Months 0 to 24

The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level.

From Months 0 to 24
Overall incidence of febrile illness
大体时间:From Months 0 to 24

The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness.

From Months 0 to 24
Mortality
大体时间:Within approximately 1 month of first presentation to the village health worker or health facility

Case fatality rates in febrile illness

Within approximately 1 month of first presentation to the village health worker or health facility
Morbidity
大体时间:Over 1 month after first presentation

Duration of illness in patients presenting with a fever to the village health worker or health facility.

Over 1 month after first presentation

次要结果测量

结果测量
措施说明
大体时间
Prevalence of pathogens in febrile patients
大体时间:Samples collected over approximately 24 months

Pathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots.

Samples collected over approximately 24 months
The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.
大体时间:Samples collected over approximately 24 months

The area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes.

Samples collected over approximately 24 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年8月4日

初级完成 (实际的)

2023年12月30日

研究完成 (实际的)

2023年12月30日

研究注册日期

首次提交

2020年7月9日

首先提交符合 QC 标准的

2020年7月15日

首次发布 (实际的)

2020年7月20日

研究记录更新

最后更新发布 (实际的)

2026年10月1日

上次提交的符合 QC 标准的更新

2026年9月30日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • BAC20001

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.

IPD 共享时间框架

After completion of trial activities and reporting

IPD 共享访问标准

MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅